3-[[[4-(Hydroxyamino)-4-oxo-butyl]-[(4-methoxyphenyl)methyl]-amino]-methyl]benzoic Acid

ID: ALA4218003

Chembl Id: CHEMBL4218003

PubChem CID: 132051446

Max Phase: Preclinical

Molecular Formula: C20H24N2O5

Molecular Weight: 372.42

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(CN(CCCC(=O)NO)Cc2cccc(C(=O)O)c2)cc1

Standard InChI:  InChI=1S/C20H24N2O5/c1-27-18-9-7-15(8-10-18)13-22(11-3-6-19(23)21-26)14-16-4-2-5-17(12-16)20(24)25/h2,4-5,7-10,12,26H,3,6,11,13-14H2,1H3,(H,21,23)(H,24,25)

Standard InChI Key:  RFYVNFBJQLLGRF-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4218003

    ---

Associated Targets(Human)

MEP1B Tchem Meprin A subunit beta (94 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 372.42Molecular Weight (Monoisotopic): 372.1685AlogP: 2.68#Rotatable Bonds: 10
Polar Surface Area: 99.10Molecular Species: ZWITTERIONHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.63CX Basic pKa: 8.59CX LogP: -0.40CX LogD: -0.42
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.44Np Likeness Score: -0.87

References

1. Ramsbeck D, Hamann A, Richter G, Schlenzig D, Geissler S, Nykiel V, Cynis H, Schilling S, Buchholz M..  (2018)  Structure-Guided Design, Synthesis, and Characterization of Next-Generation Meprin β Inhibitors.,  61  (10): [PMID:29694039] [10.1021/acs.jmedchem.8b00330]

Source